You have 9 free searches left this month | for more free features.

City

Cerritos (1)

Garden Grove (1)

Jacksonville (1)

Lauderhill (1)

Libertyville (1)

Memphis (1)

Orlando (1)

Rochester (1)

Condition

Anxiety Disorder (1)

Depressive Disorder, Major (1)

Major Depressive Disorder (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

BlackThorn Therapeutics, Inc. (1)

Mclean Hospital (1)

Collaborator

Brown University (1)

Massachusetts General Hospital (1)

Massachusetts Institute of Technology (1)

National Institute of Mental Health (NIMH) (1)

University of Washington (1)

Intervention

aversive stimuli (1)

btrx-246040 oral capsule(s) (1)

nociceptin receptor antagonist (1)

placebo oral capsule(s) (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

NOPR

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting

Depressive Disorder, Major
Anxiety Disorder

Nociceptin Receptor Antagonist
Aversive stimuli

(no location specified)

Nov 3, 2022

MDD Trial in United States (BTRX-246040 oral capsule(s), Placebo oral capsule(s))

Completed

Has Results

Major Depressive Disorder

BTRX-246040 oral capsule(s)
Placebo oral capsule(s)

Cerritos, California
+7 more

Apr 19, 2021